MaxWell Biomedical
Managing Atrial Fibrillation and Heart Failure together requires a comprehensive strategy, restoring atrial sinus rhythm and function are essential for better outcomes.
These two conditions often coexist and influence the progression of each other. When present together, they are associated with worse outcomes, including an increased risk of stroke, dementia, HF hospitalization, and all-cause mortality.
MaxWell Biomedical is innovating cardiac treatment with the development of a unique non-ablative therapy device, meticulously crafted for heart failure patients experiencing AFIB.
This pioneering technology represents a significant leap forward in the management and care of atrial fibrillation.
-
In a person with AFib, the heart beats quickly and irregularly. The atria don’t fill with blood or pump it out properly. That can make the heart work harder, weaken the heart muscle, and lead to heart failure1.
(https://www.hopkinsmedicine.org/health/conditions-and-diseases/atrial-fibrillation/afib-complications)
Functional Sinus Rhythm Does Matter
Improves HFHA Classification
Surgical Ablation of Atrial Fibrillation in Patients
With Tachycardia-Induced Cardiomyopathy
Taylan Adademir, MD,* Ali J. Khiabani, MD,* Matthew R. Schill, MD, Laurie A. Sinn, RN, BSN, Richard B. Schuessler, PhD, Marc R. Moon, MD, Spencer J. Melby, MD, and Ralph J. Damiano, Jr, MD
The MaxWell Solution
MaxWell Biomedical is at the forefront of innovation with its groundbreaking non-ablative therapy device for atrial fibrillation (AFIB), tailored for individuals suffering from heart failure.
Our innovative SRT merges the latest advancements in science and technology, offering a transformative approach to treating AFIB, particularly for those also affected by AF and heart failure (HF)—conditions known for their severity.
The unique SRT technology developed by MaxWell facilitates Active Atrial Fibrillation Management. This involves a sustained, non-invasive strategy to keep the heart in Sinus Rhythm (SR), employing an externally applied device that not only maintains a steady heartbeat but also fosters beneficial structural changes in heart failure patients with AFIB.
The device is engineered for immediate action, detecting and addressing each instance of AFIB swiftly, thus preserving a consistent rhythm and preventing the ailment from advancing. For patients maintaining sinus rhythm, the benefits include improved left atrial function, a boost in Ejection Fraction, and betterment in heart failure status.
Furthermore, MaxWell’s tele-health system offers daily monitoring, equipping physicians with ongoing, valuable data to inform patient care decisions.
Spatial Resynchronization™ Therapy System (SRT)
The Maxwell SRT System performs continuous ECG monitoring, when AFib is detected, automatic imperceptible therapy is immediately delivered to restore the heart to normal rhythm.
Imperceptible Resynchronization Therapy
The Maxwell SRT System does not require vascular access, just two small incisions, one to place the pulse generator and a second to implant the multielectrode array.
Minimally Invasive Procedure
The Maxwell SRT System offers continuous monitoring, recording, and diagnosis of AFib events and securely uploads data to the cloud for physician-patient review.